Frontiers in the COVID-19 vaccines development

Area of Science:

• * Virology and immunology
• * Vaccine development and biotechnology
• * Epidemiology and public health

Background:

• * The novel coronavirus disease (COVID-19) emerged in December 2019, rapidly spreading globally and causing significant societal disruption.
• * No specific treatments or vaccines were available at the time of the review, highlighting an urgent need for rapid vaccine development.
• * The pandemic's global impact necessitated unprecedented international scientific collaboration.

Purpose of the Study:

• * To review the current state of COVID-19 vaccine development.
• * To outline the complex stages involved in creating a safe and effective vaccine.
• * To identify key challenges and advancements in the global vaccine race.

Main Methods:

• * Comprehensive literature review of ongoing COVID-19 vaccine research and development efforts.
• * Analysis of data from the World Health Organization (WHO) on vaccine candidates.
• * Examination of the scientific processes underpinning vaccine design, manufacturing, and clinical evaluation.

Main Results:

• * As of July 13, 2020, 160 COVID-19 vaccine candidates were documented, with 26 in clinical and 137 in preclinical evaluation.
• * The development marked the first-ever evaluation of messenger RNA (mRNA)-type vaccines.
• * Multiple research organizations initiated clinical trials, demonstrating significant progress.

Conclusions:

• * COVID-19 vaccine development is a multifaceted process requiring extensive genomic studies, target identification, and rigorous safety/efficacy testing.
• * Global collaboration and scientific innovation are crucial for overcoming the challenges in vaccine production and distribution.
• * The rapid progress in vaccine candidate evaluation signifies a major scientific undertaking to combat the pandemic.